In early December, the Centers for Disease Control and Prevention (CDC) released startling numbers on the increase in deaths from drug overdose. Between the years of 2011 and 2016, the number of overdose deaths increased by 54 percent. The report notes there were 41,340 drug overdose deaths in 2011 vs 63,632 such deaths in 2016. While the opioid oxycodone was the most cited drug in overdose death records in 2011, heroin took the top spot from 2012 to 2015. In 2016 the leading drug cited in overdose deaths involved fentanyl. The CDCs list of the 10 most frequently mentioned drugs included the opioids methadone, morphine and hydrocodone; the benzos alprazolam and diazepam, and the stimulant methamphetamine. As frightening as these statistics are, it’s good to understand physicians, hospitals and behavioral health providers participating in OneHealth New Jersey can count on the new tool to supplement the currently available Prescription Drug Monitoring Program (PDMP).
The Opioid/Controlled Substances dashboard tool in OneHealth New Jersey builds upon a more comprehensive set of data than the PDMP, which only utilizes filled prescription data. The new dashboard provides participating clinicians with the list of opioids/controlled substances prescribed or administered to a clinician’s patients even before a prescription is filled at the pharmacy and even if the patient received prescriptions in multiple locations or states.
The Opioid/Controlled Substances dashboard utilizes data available through the physician-led OneHealth New Jersey health information exchange as a part of the KAMMCO network which includes the states of Kansas, Georgia, South Carolina, Connecticut, Missouri, and Louisiana and used by prescribing providers and their delegates.
KAMMCO worked with leading Kansas physicians to assess how health information exchange data could better inform physicians regarding their patients’ history of opioid/controlled substance use. They developed a tool to helps physicians to identify their patient population who received at least one prescription/administration of opioids/controlled substances and isolate patients who received overlapping opioid medications. Dashboard functionality also allows breakouts by facility and date range of opioid prescriptions, overlapping prescriptions over 12 months, and top five opioid medications prescribed/administered to their patients.
Participating physicians can access aggregated clinical data from the HIE CTHealthLink through secure web-based dashboards. Additional analytic dashboards available to participating physicians include: High Risk Patients, 30 Day Readmissions, Disease Registries, Health Care Utilization, Behavioral Health, Preventive Care Quality Reporting and Polychronic Patients.
For more information about OneHealth New Jersey, visit the website, www.onehealthnewjersey.com or call 844.424.4369.